A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate a lack of effect of venlafaxine (Effexor XR) on
QTc intervals relative to time matched placebo in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination Venlafaxine Hydrochloride